Pages that link to "Q866622"
Jump to navigation
Jump to search
The following pages link to bisphosphonate-associated osteonecrosis of the jaw (Q866622):
Displayed 50 items.
- (Q16668374) (redirect page) (← links)
- Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws (Q27025114) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw (Q28295411) (← links)
- Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases (Q33318093) (← links)
- Alendronate-associated osteonecrosis of the jaws: a review of the main topics (Q33586218) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report (Q33898150) (← links)
- Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment (Q34182079) (← links)
- A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis (Q34469883) (← links)
- Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. (Q35584343) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role (Q35605709) (← links)
- Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw. (Q35682511) (← links)
- Biphosphonates-associated osteonecrosis of the jaw: the role of gene-environment interaction (Q36478495) (← links)
- Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. (Q36581476) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines (Q36586030) (← links)
- Bisphosphonates, vitamin D, parathyroid hormone, and osteonecrosis of the jaw. Could there be a missing link? (Q36678930) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients. (Q36746430) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw (Q36767037) (← links)
- Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of the jaw. (Q36868027) (← links)
- Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates? (Q36940295) (← links)
- Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review (Q37036742) (← links)
- Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. (Q37182980) (← links)
- Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents. (Q37217775) (← links)
- Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs (Q37338781) (← links)
- Guidelines for bisphosphonate-associated osteonecrosis of the jaw. (Q37371604) (← links)
- Bisphosphonate associated osteonecrosis of the jaw. (Q37415072) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature (Q37507687) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment (Q37571013) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw: patient care considerations: overview for the orthopaedic nursing healthcare professional (Q37761015) (← links)
- Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review (Q37766313) (← links)
- A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution (Q37912798) (← links)
- Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges (Q38019444) (← links)
- The care and management of bisphosphonate--associated osteonecrosis of the jaw in the patient with multiple myeloma: a case study (Q38132367) (← links)
- Malignancy mimicking bisphosphonate-associated osteonecrosis of the jaw: a case series and literature review (Q38170771) (← links)
- Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study (Q38267866) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons. (Q38439188) (← links)
- A probable case of oral bisphosphonate-associated osteonecrosis of the jaw and recovery with parathyroid hormone treatment. (Q38560402) (← links)
- Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw. (Q38572038) (← links)
- Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature (Q38716842) (← links)
- Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphosphonates (Q39029480) (← links)
- Intravenous bisphosphonate-associated osteonecrosis of the jaw. (Q39328331) (← links)
- Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study (Q39972418) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw: are we dealing with a localized non-traditional calciphylaxis? (Q40576393) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: a histological study on biopsies (Q41986545) (← links)
- A case of bisphosphonate-associated osteonecrosis of the jaw in a patient with bone metastasis of breast cancer (Q42907260) (← links)
- Clinical experience with spiramycin in bisphosphonate-associated osteonecrosis of the jaw. (Q42964141) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? (Q43699776) (← links)
- Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series (Q45581692) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma (Q46172345) (← links)
- Re: Christan Walter, Bilal Al-Nawas, Knut A. Grötz, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 2008;54:1066-72. (Q46302349) (← links)
- Re: Christian Walter, Bilal Al-Nawas, Knut A. Grötz, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 2008;54:1066-72. (Q46417766) (← links)